SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028588
Filing Date
2023-06-16
Accepted
2023-06-16 16:01:02
Documents
12
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K pstx-20230615.htm   iXBRL 8-K 80708
  Complete submission text file 0000950170-23-028588.txt   202143

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pstx-20230615_pre.xml EX-101.PRE 10277
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pstx-20230615_lab.xml EX-101.LAB 14018
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pstx-20230615.xsd EX-101.SCH 2454
6 EXTRACTED XBRL INSTANCE DOCUMENT pstx-20230615_htm.xml XML 4940
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 231020844
SIC: 2836 Biological Products, (No Diagnostic Substances)